Study tracking care in colon cancer patients
Part of Cancer, Digestive system clinical trials.
This study follows people with colon cancer over time to learn how treatments and health changes relate to outcomes. You may be invited if your care plan includes FOLFOX and you meet certain genetic and medical history requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a colon cancer diagnosis
- You are between 18 and 79 years old
- You can understand the study and sign consent
- Your planned treatment includes FOLFOX chemotherapy
- You have Lynch syndrome or FAP (and do not have other exclusions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
This study tests whether giving additional (adjuvant) chemotherapy based on a special blood test—circulating tumor DNA (ctDNA)—can lower the risk of colon cancer coming back. It targets people with stage II–III colon cancer whose blood test is positive for minimal residual disease (MRD) after completing standard chemo.
This study follows people with colorectal cancer of any stage to learn more about their care and outcomes. It may help researchers improve treatments for future patients.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
This study enrolls people newly diagnosed with colon or rectal cancer to learn about their care and outcomes. You might be able to join if you meet the age, language, and consent requirements.
This retrospective study uses existing colorectal cancer imaging and/or preserved tissue samples to support more precise (personalized) research. It may help researchers better understand colorectal cancer over time, but it does not involve new treatment.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.